Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000820474 | SCV000961189 | likely benign | Kleefstra syndrome 1 | 2023-12-21 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV000820474 | SCV001429525 | uncertain significance | Kleefstra syndrome 1 | 2017-11-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001528830 | SCV002757081 | uncertain significance | not provided | 2022-05-23 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV002537472 | SCV003539450 | likely benign | Inborn genetic diseases | 2021-07-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Diagnostic Laboratory, |
RCV001528830 | SCV001741241 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001528830 | SCV001975115 | uncertain significance | not provided | no assertion criteria provided | clinical testing |